Terry provides strategic consultation regarding evidence planning and generation to address stakeholder needs for market access. Additionally, she participates in the design, analysis, and interpretation of global studies in health economics and outcomes research (HEOR) with a specific focus on research questions requiring real-world evidence (e.g., disease burden, patient journey [including treatment patterns], impact of diagnostics, preventatives, or interventions, as well as linking clinical trial results to clinical practice). She has experience in a variety of study designs (chart reviews, registries, pragmatic trials) and therapeutic areas including Alzheimer’s disease, immunology, migraine, oncology, and pain, and has done extensive work in respiratory conditions.
Terry worked as a pharmacist for 10 years with responsibilities for Drug Usage Evaluation, Adverse Drug Event monitoring, formulary assessment, and investigational drug service. Investigational drug studies included national cooperative trials in oncology, cardiology, and infectious disease. Additionally, she served as a voting member of the local institutional review board (IRB). Her experience in industry includes working for GlaxoSmithKline for 12 years where she initially was part of the international pharmacoeconomic group located in London. Subsequently, Terry was a senior regional medical scientist where she provided medical information to clinicians and payers, discussed and developed disease management guidelines/algorithms, and served as a link to research and development initiatives.
Terry is widely published in peer-reviewed journals and has presented her work at major professional clinical conferences. Additionally, she has been an invited lecturer on topics in her field at such institutions as the University of California San Diego, The Ohio State University, Ohio Northern University, and the University of Maryland. Terry is a member of many professional societies, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Academy of Managed Care Pharmacy (AMCP), and the American Thoracic Society (ATS). She completed her PhD from The Ohio State University with an emphasis in health outcomes and epidemiology.